← H B Fuller overview

H B Fuller vs Sherwin-Williams: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

H B Fuller Company (FUL)

Q3 2026
▲2▼1

Fuller's profit jumps, AMS deal and Ancora bid reshape outlook

  • Strong profit growth and pricing Q2 profit rose 19% to $1.41 per share and Q3 profit jumped 21% to $1.52 per share, helped by 7.4% higher prices. All business units grew and profit margins expanded.

    This is the core positive driver of the quarter, showing broad-based earnings strength.

  • Advanced Medical Solutions acquisition Fuller is buying Advanced Medical Solutions for £715 million, moving into higher-growth medical adhesives. This expands its healthcare business and could boost future sales and profits.

    A major strategic move that shifts the company toward faster-growing markets.

  • Ancora's bid for Building Adhesives unit Activist investor Ancora raised its offer for Fuller's Building Adhesives unit to $1.4 billion. The public fight highlights that the unit may be undervalued, but it also creates uncertainty about the company's future structure.

    This event signals potential value but also introduces uncertainty, making it a mixed driver.

  • Rising debt and borrowing costs The AMS deal pushes debt to about 4 times earnings. Fuller also priced $850 million in 7.625% senior notes and refinanced $420 million, meaning higher interest costs that could squeeze future profits and increase financial risk.

    This is the main risk weighing on the stock, as higher debt and interest expenses could pressure earnings.

August 2026
▲1▼1

Fuller's profit engine hums, but debt and a buyout fight weigh

  • Q3 profit jumps 21% on pricing power Fuller's third-quarter profit rose 21% to $1.52 a share, beating estimates, as 7.4% price increases offset lower volumes. All three business units grew, and margins expanded. This shows the core adhesives business is getting stronger, which supports a higher stock price.

    This is the main new fundamental driver of FUL's value this period.

  • Ancora raises bid for building adhesives unit to $1.4B Activist Ancora lifted its cash offer for Fuller's Building Adhesives unit to as much as $1.4 billion, about half Fuller's market value, after the board rejected its earlier bid. The board says the unit is worth more. A sale could unlock value, but the public fight adds uncertainty.

    The raised bid is a major new event that could reshape the company and its stock.

  • AMS acquisition advances but adds debt risk Advanced Medical Solutions shareholders approved Fuller's £715 million purchase, moving the medical-adhesives deal closer to closing by year-end. It should boost long-term growth, but will push debt to about 4 times earnings, and analysts trimmed fair value on execution risk.

    The deal's progress and its balance-sheet impact are key new developments.

  • High-cost debt refinancing and new notes Fuller refinanced $420 million of loans and priced $850 million of 7.625% senior notes due 2034. The high interest rate signals lenders demand a premium, raising future interest costs and squeezing profits. This weighs on the stock by increasing financial risk.

    The expensive new debt is a fresh negative for FUL's finances.

Latest
▲1▼1

Fuller's profit engine hums, but debt and a buyout fight weigh

  • Q3 profit jumps 21% on pricing power Fuller's third-quarter profit rose 21% to $1.52 a share, beating estimates, as 7.4% price increases offset lower volumes. All three business units grew, and margins expanded. This shows the core adhesives business is getting stronger, which supports a higher stock price.

    This is the main new fundamental driver of FUL's value this period.

  • Ancora raises bid for building adhesives unit to $1.4B Activist Ancora lifted its cash offer for Fuller's Building Adhesives unit to as much as $1.4 billion, about half Fuller's market value, after the board rejected its earlier bid. The board says the unit is worth more. A sale could unlock value, but the public fight adds uncertainty.

    The raised bid is a major new event that could reshape the company and its stock.

  • AMS acquisition advances but adds debt risk Advanced Medical Solutions shareholders approved Fuller's £715 million purchase, moving the medical-adhesives deal closer to closing by year-end. It should boost long-term growth, but will push debt to about 4 times earnings, and analysts trimmed fair value on execution risk.

    The deal's progress and its balance-sheet impact are key new developments.

  • High-cost debt refinancing and new notes Fuller refinanced $420 million of loans and priced $850 million of 7.625% senior notes due 2034. The high interest rate signals lenders demand a premium, raising future interest costs and squeezing profits. This weighs on the stock by increasing financial risk.

    The expensive new debt is a fresh negative for FUL's finances.

July 2026
▲2

Fuller's profit beat and buyout battle reshape its path

  • Strong Q2 earnings and raised guidance Fuller's second-quarter profit rose 19% to $1.41 per share, revenue grew 5.8%, and the company raised its full-year profit outlook. This shows the core business is performing well, which supports a higher stock price.

    This is the main positive fundamental driver for FUL's price this period.

  • Acquisition of Advanced Medical Solutions Fuller agreed to buy Advanced Medical Solutions for £715 million, moving into higher-growth medical adhesives. The deal should boost long-term growth but will temporarily raise debt to about 4 times earnings, and an activist investor opposes it.

    This is a major strategic move that affects FUL's growth and risk profile.

  • Ancora's buyout offer for building adhesives unit Ancora offered $1.1–1.2 billion for Fuller's Building Adhesives Solutions unit, but the board rejected it as too low. The offer highlights the unit's value and could pressure management to unlock it, potentially lifting the stock.

    This event shows external interest in Fuller's assets and could lead to value creation.

▲2

Fuller's profit beat and buyout battle reshape its path

  • Strong Q2 earnings and raised guidance Fuller's second-quarter profit rose 19% to $1.41 per share, revenue grew 5.8%, and the company raised its full-year profit outlook. This shows the core business is performing well, which supports a higher stock price.

    This is the main positive fundamental driver for FUL's price this period.

  • Acquisition of Advanced Medical Solutions Fuller agreed to buy Advanced Medical Solutions for £715 million, moving into higher-growth medical adhesives. The deal should boost long-term growth but will temporarily raise debt to about 4 times earnings, and an activist investor opposes it.

    This is a major strategic move that affects FUL's growth and risk profile.

  • Ancora's buyout offer for building adhesives unit Ancora offered $1.1–1.2 billion for Fuller's Building Adhesives Solutions unit, but the board rejected it as too low. The offer highlights the unit's value and could pressure management to unlock it, potentially lifting the stock.

    This event shows external interest in Fuller's assets and could lead to value creation.

Sherwin-Williams Co (SHW)

Q3 2026
▲3▼1

Sherwin-Williams beats Q2, raises guidance, but valuation and risks temper outlook

  • Strong Q2 earnings and raised guidance Sherwin-Williams reported Q2 adjusted EPS of $3.70, beating estimates, on revenue of $6.79 billion, up 7.5%. The company raised full-year guidance to near $12 EPS, sending the stock up 7.5–8.3%.

    This is the main positive event that drove the stock during the period.

  • Growth from new accounts and share gains Growth came from new account wins and market share gains, especially in Protective & Marine coatings for data centers and semiconductors. An 8% September price hike also helped offset raw material inflation.

    These operational successes contributed to revenue growth and margin protection.

  • Cost savings and new product launch Store closures are saving about $17 million annually, and the company launched a new eco-friendly Krylon spray paint, which could support future sales and efficiency.

    These actions improve profitability and product offerings.

  • Risks temper outlook despite analyst fair value Higher prices could dampen demand, housing softness and supply-chain issues (including the Strait of Hormuz closure) may pressure margins, and the stock trades at ~30x earnings, above industry averages, leaving a mixed valuation picture despite analyst fair value of $372.95.

    These risks could limit upside and are important counterweights to the positive drivers.

August 2026
▲3

Earnings Beat, Raised Guidance, and Price Hikes Drive Sherwin-Williams

  • Strong Q2 Earnings and Raised Guidance Sherwin-Williams beat second-quarter estimates with adjusted earnings of $3.70 per share and revenue up 7.5% to $6.79 billion. The company raised full-year profit guidance, signaling confidence. This positive news pushed the stock up 7.5% and supports higher prices ahead.

    This is the core positive fundamental driver that directly lifted the stock and improved future outlook.

  • 8% Price Increase to Offset Costs Sherwin-Williams is raising prices by 8% starting September 1 to counter higher raw material costs from the Strait of Hormuz closure. This protects profit margins and shows pricing power. The stock rose over 8% after the announcement, though higher prices could eventually dampen demand.

    This explains a key margin-protection move and its immediate positive market reaction.

  • New Water-Based Spray Paint Launch Krylon, a Sherwin-Williams brand, launched Harmony, a water-based spray paint that reduces odor and flammability. This expands the product line into eco-friendly and user-friendly options, potentially boosting sales in DIY and professional markets. Success depends on retailer adoption and repeat purchases.

    This product innovation could drive future revenue growth and shows the company's focus on meeting consumer trends.

  • Dividend and Valuation Concerns Sherwin-Williams declared a $0.80 quarterly dividend, but the stock trades at about 30 times earnings, above industry average. Analysts see fair value at $372.95, implying undervaluation, yet risks like softer housing demand and supply chain issues could pressure margins. This creates a mixed outlook for investors.

    This highlights the balance between income and valuation risks that investors should weigh.

Latest
▲3

Earnings Beat, Raised Guidance, and Price Hikes Drive Sherwin-Williams

  • Strong Q2 Earnings and Raised Guidance Sherwin-Williams beat second-quarter estimates with adjusted earnings of $3.70 per share and revenue up 7.5% to $6.79 billion. The company raised full-year profit guidance, signaling confidence. This positive news pushed the stock up 7.5% and supports higher prices ahead.

    This is the core positive fundamental driver that directly lifted the stock and improved future outlook.

  • 8% Price Increase to Offset Costs Sherwin-Williams is raising prices by 8% starting September 1 to counter higher raw material costs from the Strait of Hormuz closure. This protects profit margins and shows pricing power. The stock rose over 8% after the announcement, though higher prices could eventually dampen demand.

    This explains a key margin-protection move and its immediate positive market reaction.

  • New Water-Based Spray Paint Launch Krylon, a Sherwin-Williams brand, launched Harmony, a water-based spray paint that reduces odor and flammability. This expands the product line into eco-friendly and user-friendly options, potentially boosting sales in DIY and professional markets. Success depends on retailer adoption and repeat purchases.

    This product innovation could drive future revenue growth and shows the company's focus on meeting consumer trends.

  • Dividend and Valuation Concerns Sherwin-Williams declared a $0.80 quarterly dividend, but the stock trades at about 30 times earnings, above industry average. Analysts see fair value at $372.95, implying undervaluation, yet risks like softer housing demand and supply chain issues could pressure margins. This creates a mixed outlook for investors.

    This highlights the balance between income and valuation risks that investors should weigh.

July 2026
▲4

Sherwin-Williams beats, raises guidance, and announces 8% price hike

  • Earnings beat and raised full-year guidance Sherwin-Williams reported second-quarter adjusted earnings of $3.70 per share on $6.79 billion in revenue, beating estimates, and raised its full-year adjusted EPS guidance to a midpoint of $12. The stock jumped 7.5-8.3% as investors welcomed the strong results and outlook.

    This is the core new event that directly drove the stock's sharp move this period.

  • 8% price hike to offset raw material inflation The company announced an 8% price increase effective September 1 to counter accelerating raw material inflation, which is expected to reach high single digits in the second half. This supports margins and profitability, a key reason for the stock's rise.

    The price hike is a new, specific action that helps explain why the company can maintain profits despite cost pressures.

  • Market share gains and new account wins Sherwin-Williams attributed its strong growth to aggressive new account wins and share gains, not a broad demand recovery. Its Paint Stores Group saw momentum in Protective and Marine, especially in data centers and semiconductor infrastructure, which boosts revenue and investor confidence.

    This shows the company is growing even without a market recovery, a key driver of the raised guidance.

  • Store optimization and cost savings The company closed 57 underperforming stores and expects restructuring to yield about $17 million in annual savings, with half realized in 2026. It also plans to return to the high end of its 80-100 net new store opening target in 2027, supporting long-term profitability.

    These actions improve efficiency and future growth prospects, contributing to the positive outlook.

▲4

Sherwin-Williams beats, raises guidance, and announces 8% price hike

  • Earnings beat and raised full-year guidance Sherwin-Williams reported second-quarter adjusted earnings of $3.70 per share on $6.79 billion in revenue, beating estimates, and raised its full-year adjusted EPS guidance to a midpoint of $12. The stock jumped 7.5-8.3% as investors welcomed the strong results and outlook.

    This is the core new event that directly drove the stock's sharp move this period.

  • 8% price hike to offset raw material inflation The company announced an 8% price increase effective September 1 to counter accelerating raw material inflation, which is expected to reach high single digits in the second half. This supports margins and profitability, a key reason for the stock's rise.

    The price hike is a new, specific action that helps explain why the company can maintain profits despite cost pressures.

  • Market share gains and new account wins Sherwin-Williams attributed its strong growth to aggressive new account wins and share gains, not a broad demand recovery. Its Paint Stores Group saw momentum in Protective and Marine, especially in data centers and semiconductor infrastructure, which boosts revenue and investor confidence.

    This shows the company is growing even without a market recovery, a key driver of the raised guidance.

  • Store optimization and cost savings The company closed 57 underperforming stores and expects restructuring to yield about $17 million in annual savings, with half realized in 2026. It also plans to return to the high end of its 80-100 net new store opening target in 2027, supporting long-term profitability.

    These actions improve efficiency and future growth prospects, contributing to the positive outlook.